During the past decade, Aultman Cardiology Clinical Trials conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aultman Cardiology Clinical Trials" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Aultman Cardiology Clinical Trials" are "Gastrointestinal Tolerance" (2 trials), "Clostridium Difficile Infection" (1 trials), "Heart Failure" (1 trials) and "Iron-deficiency" (1 trials). Many other conditions were trialed in "Aultman Cardiology Clinical Trials" in a lesser frequency.

Most popular intervention types in "Aultman Cardiology Clinical Trials" are "Other" (2 trials), "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Active Comparator: Control Infant Formula" (1 trials), "Clostridium difficile vaccine" (1 trials), "Experimental Infant Formula 1" (1 trials) and "Experimental Infant Formula 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aultman Cardiology Clinical Trials" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Aultman Cardiology Clinical Trials". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Aultman Cardiology Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aultman Cardiology Clinical Trials, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".